» Articles » PMID: 37657945

Nuclear Pore Complex and Nucleocytoplasmic Transport Disruption in Neurodegeneration

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2023 Sep 1
PMID 37657945
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear pore complexes (NPCs) play a critical role in maintaining the equilibrium between the nucleus and cytoplasm, enabling bidirectional transport across the nuclear envelope, and are essential for proper nuclear organization and gene regulation. Perturbations in the regulatory mechanisms governing NPCs and nuclear envelope homeostasis have been implicated in the pathogenesis of several neurodegenerative diseases. The ESCRT-III pathway emerges as a critical player in the surveillance and preservation of well-assembled, functional NPCs, as well as nuclear envelope sealing. Recent studies have provided insights into the involvement of nuclear ESCRT-III in the selective reduction of specific nucleoporins associated with neurodegenerative pathologies. Thus, maintaining quality control of the nuclear envelope and NPCs represents a pivotal element in the pathological cascade leading to neurodegenerative diseases. This review describes the constituents of the nuclear-cytoplasmic transport machinery, encompassing the nuclear envelope, NPC, and ESCRT proteins, and how their structural and functional alterations contribute to the development of neurodegenerative diseases.

Citing Articles

Postexercise downregulation of in regulating non-small cell lung cancer progression via the PTEN/AKT signaling pathway.

Xu J, Zhang L, Feng M, Hong W, Ye X Transl Cancer Res. 2024; 13(11):6323-6335.

PMID: 39697746 PMC: 11651763. DOI: 10.21037/tcr-24-1619.


Nuclear pore and nucleocytoplasmic transport impairment in oxidative stress-induced neurodegeneration: relevance to molecular mechanisms in Pathogenesis of Parkinson's and other related neurodegenerative diseases.

Riaz Z, Richardson G, Jin H, Zenitsky G, Anantharam V, Kanthasamy A Mol Neurodegener. 2024; 19(1):87.

PMID: 39578912 PMC: 11585115. DOI: 10.1186/s13024-024-00774-0.


Heterogeneous Nuclear Ribonucleoprotein A1 Knockdown Alters Constituents of Nucleocytoplasmic Transport.

Stang T, Salapa H, Clarke J, Popescu B, Levin M Brain Sci. 2024; 14(10).

PMID: 39452051 PMC: 11505608. DOI: 10.3390/brainsci14101039.


Cytoplasmic nucleoporin assemblage: the cellular artwork in physiology and disease.

Lin J, Sumara I Nucleus. 2024; 15(1):2387534.

PMID: 39135336 PMC: 11323873. DOI: 10.1080/19491034.2024.2387534.


Nuclear and degradative functions of the ESCRT-III pathway: implications for neurodegenerative disease.

Keeley O, Coyne A Nucleus. 2024; 15(1):2349085.

PMID: 38700207 PMC: 11073439. DOI: 10.1080/19491034.2024.2349085.

References
1.
Frost B, Hemberg M, Lewis J, Feany M . Tau promotes neurodegeneration through global chromatin relaxation. Nat Neurosci. 2014; 17(3):357-66. PMC: 4012297. DOI: 10.1038/nn.3639. View

2.
Coyne A, Rothstein J . The ESCRT-III protein VPS4, but not CHMP4B or CHMP2B, is pathologically increased in familial and sporadic ALS neuronal nuclei. Acta Neuropathol Commun. 2021; 9(1):127. PMC: 8287756. DOI: 10.1186/s40478-021-01228-0. View

3.
Ghazi-Noori S, Froud K, Mizielinska S, Powell C, Smidak M, Fernandez de Marco M . Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. Brain. 2012; 135(Pt 3):819-32. DOI: 10.1093/brain/aws006. View

4.
Guo L, Kim H, Wang H, Monaghan J, Freyermuth F, Sung J . Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains. Cell. 2018; 173(3):677-692.e20. PMC: 5911940. DOI: 10.1016/j.cell.2018.03.002. View

5.
Baade I, Kehlenbach R . The cargo spectrum of nuclear transport receptors. Curr Opin Cell Biol. 2018; 58:1-7. DOI: 10.1016/j.ceb.2018.11.004. View